GG

Girish Govind Narkar

Active Director Designated Partner DIN 06443025
DIN 06443025 First appointment Jan 2013 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2013
Shareholding value β€’β€’β€’β€’ Premium profile

About Girish Govind Narkar

Data last updated:

Girish Govind Narkar is a Designated Partner at Govind Medicare Llp (since 2013). The company operates in Pharma.

DIN 06443025
Primary Designation Designated Partner
Industry Pharma
First Appointment 17 Jan 2013
Oldest Company Age 13 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner17 Jan 20132013Active

Board colleagues of Girish Govind Narkar

NameDINCompanyDesignation
Santosh Vishwanath Channa06896010Govind Medicare LlpDesignated Partner
Shradha Girish Narkar06443030Govind Medicare LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Govind Medicare Llp
Premium access

Shareholding and investment profile for Girish Govind Narkar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Girish Govind Narkar

Girish Govind Narkar currently holds 1 directorship: Govind Medicare Llp (Designated Partner, since 17 Jan 2013).

Girish Govind Narkar was first appointed on 17 Jan 2013 as Designated Partner at Govind Medicare Llp.

The current boards of Girish Govind Narkar's companies include Santosh Vishwanath Channa (Govind Medicare Llp), Shradha Girish Narkar (Govind Medicare Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available